The Rise of GIP: From Biology to Medicine
Update: 2025-05-16
Description
Delve into the evolving story of GIP-based therapies and their role in type 2 diabetes care. In this episode, our expert guests explore how dual and triple agonists like tirzepatide are reshaping obesity and metabolic control, and why GIP is gaining renewed attention in diabetes pharmacology.
You can also explore each speakers' profiles as well as watch each speaker’s Lecturesession from the EASD Annual Meeting 2024 for deeper insights into incretin science, clinical outcomes, and next-generation therapies:
- Prof. Michael Nauck's Profile and EASD 2024 Lecture
- Dr. Alice Adriaenssens' Profile and EASD 2024 Lecture
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
